US-Israel Aggression and the Soaring Cost of Medicine in Iran
Reports indicate that the price of essential medicines in Iran, including common painkillers and contraceptives, has seen a dramatic increase, in some cases quadrupling, amidst the ongoing US-Israel joint military operation against the Islamic Republic. This surge in costs makes critical medical supplies increasingly inaccessible for the average Iranian household, directly linking military
aggression and persistent sanctions to public health outcomes. Al Jazeera, in its reporting, observes these rising medicine costs as a consequence of the 'Iran war.' However, this framing obscures the fundamental nature of the engagement. The United States is not a distant observer or mere supporter but a direct participant and joint aggressor in this campaign, fighting alongside Israel. This
involves not only naval deployments and air exercises but also sustained economic warfare that predates current military posturing, aiming to destabilize the Iranian administration through attrition. While Western media often categorizes such price spikes as market fluctuations in a 'war-torn region,' the reality for Iran is a deliberate policy of economic strangulation, leveraging sanctions to
cripple its economy and civilian infrastructure, a tactic intensified by explicit military threats. This current scenario echoes a chilling precedent, demonstrating how economic warfare directly targets civilian populations. In 1999, reports emerged from Iraq documenting a significant increase in infant mortality and childhood diseases, directly attributed to the US-led sanctions regime following